Chang, Annette M., and Jeffrey B. Halter. Aging and insulin secretion. Am J Physiol Endocrinol Metab 284: E7-E12, 2003; 10.1152/ ajpendo.00366.2002.-Glucose tolerance progressively declines with age, and there is a high prevalence of type 2 diabetes and postchallenge hyperglycemia in the older population. Age-related glucose intolerance in humans is often accompanied by insulin resistance, but circulating insulin levels are similar to those of younger people. Under some conditions of hyperglycemic challenge, insulin levels are lower in older people, suggesting -cell dysfunction. When insulin sensitivity is controlled for, insulin secretory defects have been consistently demonstrated in aging humans. In addition, -cell sensitivity to incretin hormones may be decreased with advancing age. Impaired -cell compensation to agerelated insulin resistance may predispose older people to develop postchallenge hyperglycemia and type 2 diabetes. An improved understanding of the metabolic alterations associated with aging is essential for the development of preventive and therapeutic interventions in this population at high risk for glucose intolerance. aged humans; -cell function GLUCOSE TOLERANCE PROGRESSIVELY DECLINES with age, resulting in a high prevalence of type 2 diabetes and impaired glucose tolerance in the older population (21). The interaction of many factors associated with aging likely contributes to the alterations in glucose tolerance in this population. These factors include increased adiposity, decreased physical activity, medications, coexisting illness, and insulin secretory defects associated with the aging process. The mechanism of age-related glucose intolerance is not completely clear. This article will review the epidemiology of age-related glucose intolerance and the effects of aging on insulin secretion in humans.
EPIDEMIOLOGY OF AGE-RELATED CHANGES IN GLUCOSE METABOLISMAs shown in Fig. 1, according to the Third National Health and Nutrition Examination Survey (NHANES III) conducted from 1988 to 1994, the prevalence of type 2 diabetes in Americans 60-74 yr of age is Ͼ20% (22, 41). This percentage includes cases previously diagnosed by medical history and those newly diagnosed by fasting glucose or by oral glucose tolerance testing (OGTT). An additional 20% of this population meets criteria for impaired glucose tolerance (IGT), defined as a 2-h glucose level Ն140 mg/dl but Ͻ200 mg/dl by OGTT, and a fasting blood glucose not in the diabetic range (Ͻ126 mg/dl) (22). Prevalence data from 1976 to 1980 from NHANES II for diabetes and IGT in Americans 60-74 yr of age were similar (23); thus the high prevalence of glucose intolerance in the older population has persisted over the past two decades. Additional studies of older adults, including the Cardiovascular Health Study and Honolulu Heart Study, show that the high prevalence of diabetes and IGT continues in people over age 75 (46, 43).Isolated postchallenge hyperglycemia (IPH), defined as a 2-h glucose level Ն200 mg/dl by OGTT but a fasting glucose...